Jump to content

Talk:Pertuzumab

Page contents not supported in other languages.
From Wikipedia, the free encyclopedia

APHINITY confirmatory trial

[edit]

APHINITY is the confirmatory trial for the September 2013 accelerated approval. Phase III Trial Results Confirm Adjuvant Pertuzumab Success in HER2+ Breast Cancer - Could mention in History or a new Clinical trials section ? - Rod57 (talk) 18:05, 20 March 2017 (UTC)[reply]